课题基金 / 基金详情

负载PTHrP诱导干细胞源性外泌体的负泊松比钛支架修复骨质疏松性骨缺损的效果和机制研究

批准号:
82102542
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
王端
依托单位:
学科分类:
骨、关节、软组织医用材料
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
王端

项目摘要

结项摘要

相似基金

相关文献

中文摘要
骨质疏松性骨缺损修复是临床治疗的难题,骨修复材料的力学适配性、生物活性和抗骨质疏松性是解决问题的关键。前期研究发现甲状旁腺激素相关蛋白类似物(PTHrP)可刺激间充质干细胞旁分泌富含miRNA的外泌体(PTHrP-Exo),促进血管化骨再生,修复骨质疏松性骨缺损。本项目拟将PTHrP-Exo引入负泊松比钛支架,构建兼具力学适配和血管化骨再生性的骨修复材料。首先,优化具有最佳生物活性外泌体的富集方式,通过RNA测序和生物信息学明确其促进血管化骨再生的关键miRNA及作用机制;其次,利用3D打印制备具有力学适配性的负泊松比钛支架,优化电化学工艺参数,在界面构建晶体形貌可控的硅-羟基磷灰石涂层(Si-HA),再通过化学键性结合负载最佳生物活性外泌体,分别从体内外研究该材料在促进骨质疏松来源的细胞成血管和成骨分化,以及骨质疏松性骨缺损修复中的作用,为临床骨质疏松性骨缺损的修复提供材料基础。
英文摘要
Osteoporotic bone defect repair remains a challenge in the clinical treatment, the mechanical adaptability, bioactivity, and anti-osteoporosis ability are critical requirements for bone repair materials. Previously, parathyroid hormone-related protein analogues (PTHrP) was discovered to stimulate mesenchymal stem cells to produce miRNA-rich exosomes (PTHrP-Exo) through paracrine pathways, which can enhance vascularized bone regeneration and repair osteoporotic bone defects. This study aimed to construct an auxetic titanium scaffold coated with PTHrP-Exo, which have good mechanical adaptability and vascularized bone regenerative activity. Firstly, we will optimize the enrichment method of exosomes with the best biological activity, and clarify the mechanism of the key miRNA to promote vascularized bone regeneration by the method of RNA sequencing and bioinformatics. Secondly, the auxetic titanium scaffold with mechanical adaptability will be constructed with the use of 3D printing technique. In addition, we will construct controllably bioactive hydroxyapatite and silicon micro-nano structure coating on the interface of the titanium scaffold. The bioactive PTHrP-Exo will be also load on the interface through chemical bonding. This constructed bioactive titanium scaffold will be studied regarding the promotion of the angiogenesis and osteogenic differentiation of osteoporotic-derived cells and the repair of osteoporotic bone defects. With the feedback from in vitro and vivo experiments, we hope to optimize the material fabrication process to the clinical osteoporotic bone defect repair.
骨质疏松性承重骨缺损是临床治疗的重大挑战,传统骨修复材料在力学适配性、生物活性及抗骨质疏松性方面存在明显不足,难以满足临床需求。甲状旁腺激素相关蛋白类似物(PTHrP)已被发现可以刺激间充质干细胞旁分泌富含miRNA的外泌体(PTHrP-Exo),显著促进血管化骨再生。本项目以构建兼具力学适配性和血管化骨再生性能的新型骨修复材料为目标,为骨质疏松性承重大段骨缺损的修复提供新思路。我们优化外泌体富集方式,明确PTHrP-Exo的关键miRNA及其促进血管化骨再生的机制;利用3D打印技术制备具有力学适配性的负泊松比钛支架,优化电化学工艺,构建晶体形貌可控的硅-羟基磷灰石(Si-HA)涂层;将PTHrP-Exo功能化负载至Si-HA涂层支架,通过体内外实验评价其促进骨质疏松性承重骨缺损修复的性能。主要结果如下:1、优化富集的PTHrP-Exo显著促进血管化和成骨分化,其关键miRNA通过调控血管内皮生长因子和成骨相关信号通路发挥作用;2、制备的负泊松比钛支架具有优异的力学适配性,其抗压强度明显提升,弹性模量与松质骨接近;Si-HA涂层的晶体形貌和厚度显著提高其表面结合能力和生物活性;3、在体外实验中,PTHrP-Exo功能化支架显著提高细胞的血管化和成骨分化。体内实验表明,该复合材料在兔大段骨缺损模型中的新骨形成率提高约60%,显著促进骨整合和功能重建。本项目结合生物活性外泌体技术与先进的3D打印及涂层工艺,构建兼具力学适配性和血管化骨再生性能的新型骨修复材料。研究揭示了PTHrP-Exo在血管化骨再生中的关键作用及其分子机制,为骨质疏松性承重骨缺损的治疗提供新策略,具有重要的科学价值和临床转化潜力。
国内基金
海外基金